SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    WHO. Obesity, Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva June 1997. WHO/NUT/NCD/98. 1.
  • 2
    Bray GA. Obesity: a time bomb to be defused. Lancet. 1998; 352: 1601.
  • 3
    Kassirer JP, Angell M. Losing weight—an ill fated new year's resolution. N Engl J Med. 1998;338: 524.
  • 4
    Peters ETJ, Seidell JC, Menotti A., et al. Changes in body weight in relation to mortality in 6441 European middle-aged men: The seven countries study. Int J Obes. 1995;19: 8628.
  • 5
    Pamuk ER, Williamson DF, Serdula MK, Madans J., Byers TE. Weight loss and subsequent death in a cohort of U. S. adults. Ann Intent Med. 1993; 119: 7448.
  • 6
    Walker M., Wannamethee G., Whincup PH, Shaper AG. Weight change and risk of heart attack in middle-aged british men. Int J Epidemiol. 1995;24: 694703.
  • 7
    Ashley FW, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham study. J Chron Dis. 1974;27: 10314.
  • 8
    Schotte DE, Stunkard AJ. The effects of weight reduction on blood pressure in 301 obese patients. Arch Intern Med. 1990; 150: 17014.
  • 9
    Sjöström CD, Lissner L., Sjöström L. Relationships between changes in body composition and changes in cardiovascular risk factors: The SOS Intervention Study. Obes Res. 1997; 5: 51930.
  • 10
    Eriksson KF, Lindgärde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical ex ercise. The 6-year Malmö feasibility study. Diaberologia. 1991: 34: 8918.
  • 11
    Wing RR, Venditti E., Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Cure. 1998;21: 3509.
  • 12
    Long SD, O'Brien K., MacDonald KG Jr, et al. Weight loss in severely obese subjects prevents the progression of im paired glucose tolerance to type II diabetes. A longitudinal intervention study. Diabetes Care. 1994: 17: 3725.
  • 13
    French SA, Jeffery RW, Folsom AR, Williamson DF, Byers T. History of intentional and unintentional weight loss in a population-based sample of women aged 55 to 69 years. Obes Res. 1995;3: 16370.
  • 14
    Williamson DF, Pamuk E., Thun M., Flanders D., Byers T., Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 Years. Am J Epidemiol. 1995;141: 112841.
  • 15
    Sjöström L., Larsson B., Backman L., et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes. 1992; 16: 46579.
  • 16
    Sullivan M., Karlsson J., Sjöström L., et al. Swedish obese subjects (SOS) - an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Inr J Obes. 1993: 17: 50312.
  • 17
    Deitel M. (ed). Surgery for the morbidly obese patient. Phila delphia: Lea & Febiger. 1989.
  • 18
    Safer DJ. Diet, behavior modification, and exercise: A review of obesity treatments from a long-term perspective. South Med J. 1991;84: 14704.
  • 19
    Maxwell MH, Waks AU, Schroth PC, Karam M., Dornfeld LP. Error in blood-pressure measurement due to incorrect cuff size in obese patients. Lancet. 1982;3: 336.
  • 20
    Subcommittee of WHO/ISH Mild Hypertension Liaison Committee. Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the man agement of mild hypertension. BMJ. 1993;307: 15416.
  • 21
    The Expert Panel. Report of the National Cholesterol Edu cation Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148: 3669.
  • 22
    Report of a WHO Study Group. Prevention of Diabetes Mellitus. WHO Tech Rep Ser. 1994;844: 1100.
  • 23
    Egger M., Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315: 15337.
  • 24
    Sjöström L., Rissanen A., Andersen T., et al. Weight loss and prevention of weight regain in obese patients: a 2-year, Euro pean, randomized trial of orlistat. Lancet. 1998;352: 16772.
  • 25
    Sjöström CD, Håkangård AC, Lissner L., Sjöström L. Body compartment and subcutaneous adipose tissue distribution-risk factor patterns in obese subjects. Obes Res. 1995; 3: 922.
  • 26
    Williamson DF, Pamuk E., Thun M., Flanders D., Heath C., Byers T. Prospective study of intentional weight loss and mortality in overweight men aged 40–64 years. Obes Res. 1997; 5: 94S (abstr.).
  • 27
    Allison DB, Heo M., Flanders DW, Faith MS, Williamson DF. Examination of “early mortality exclusion” as an ap proach to control for confounding by occult disease in epidemiologic studies of mortality risk factors. Am J Epidemiol. 1997; 146: 67280.
  • 28
    Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes. 1992; 16: 397415.
  • 29
    Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222: 33952.
  • 30
    Davidson MH, Hauptman J., DiGirolamo M., et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281: 23542.
  • 31
    Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337: 5818.